{
  "metadata": {
    "contact_id": "CNT-c9M007641",
    "eni_id": "MANUAL-CNT-c9M007641-9ENI",
    "member_name": "Gregg Fergus",
    "generated_at": "2025-08-05T16:19:30.000000",
    "generator": "structured_insight",
    "system_prompt_key": "structured_insight",
    "context_files": "combined_all_eni_groups",
    "record_count": 9,
    "total_eni_ids": 9
  },
  "insights": {
    "raw_content": "```json\n{\n  \"personal\": \"* Completed over 10 Ironman races showing strong personal dedication\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Avid golfer maintaining active athletic interests\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Strong commitment to personal fitness and endurance activities\\n  * [2025-08-05,ENI-0421921989327972304]\",\n  \"business\": \"* Board Chair at Ascertain\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Board of Directors at Optain, Neuvivo, AIQ Solutions, Aqtual, and Verda Bio\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Former CEO at 4Catalyzer where he co-founded, funded, and scaled startups\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Successfully led companies to IPO including Butterfly Network, QSi, and Hyperfine\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Pivotal role in Ion Torrent acquisition by Life Technology for $725M pre-revenue\\n  * [2025-08-05,ENI-0421921989327972304]\",\n  \"investing\": \"* Interested in asset classes: Blockchain, Credit, Hedge Funds, Private Equity, Real Estate, Venture Capital\\n  * [2025-08-05,ENI-05883655826784470444]\\n* Extensive fundraising expertise - raised over $800M in capital\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Focus on democratizing healthcare and maximizing societal impact through entrepreneurial ventures\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Experience in genomics, proteomics, drug development, med tech, diagnostics, and agriculture\\n  * [2025-08-05,ENI-0421921989327972304]\\n* Balanced risk appetite combining high-risk, high-reward investments with stable options\\n  * [2025-08-05,ENI-05883655826784470444]\",\n  \"3i\": \"\",\n  \"deals\": \"**This Member Has Experience** and Is Comfortable Diligencing These Asset Classes & Sectors\\n- Life Sciences and Biotechnology (genomics, proteomics, drug development)\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Med Tech and Diagnostics\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Agriculture Technology\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Startup Acceleration and Scaling\\n  * [2025-08-05,ENI-0421921989327972304]\\n\\n**This Member Is Interested In Exploring** These Asset Classes, Sectors, and Strategies\\n- Blockchain\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Credit\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Hedge Funds\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Private Equity\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Real Estate\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Venture Capital\\n  * [2025-08-05,ENI-05883655826784470444]\",\n  \"introductions\": \"**Looking to meet:**\\n- Other life sciences executives and board members\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Startup founders in healthcare and biotechnology\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Investment professionals in venture capital and private equity\\n  * [2025-08-05,ENI-05883655826784470444]\\n- Athletic and networking event participants\\n  * [2025-08-05,ENI-0421921989327972304]\\n\\n**Value proposition for introductions:**\\n- Extensive fundraising expertise ($800M+ raised)\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Multiple successful IPO experiences\\n  * [2025-08-05,ENI-0421921989327972304]\\n- Strategic acquisition experience\\n  * [2025-08-05,ENI-0421921989327972304]\"\n}\n```"
  }
} 